Teleflex Incorporated
TFX
Helyezés a részvények között
#3216
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Részvényárfolyam
$130.34
Piaci kapitalizáció
$5.52B
Változás (1 nap)
-0.51%
Változás (1 év)
-2.04%
Ország
US
Kereskedés Teleflex Incorporated (TFX)
Kategória
Healthcare
Bevétel a(z) Teleflex Incorporated (TFX) részvényhez
Bevétel ekkor: Jun 2026 TTM: $2.60B
Teleflex Incorporated legfrissebb pénzügyi jelentései szerint a vállalat jelenlegi árbevétele (TTM) $2.60B. 2023 évben a vállalat $2.97B árbevételt ért el, amely növekedés a 2022 évben elért $2.79B árbevételhez képest. Az árbevétel az a teljes összeg, amit a vállalat termékek vagy szolgáltatások eladásából generál. A nyereséggel ellentétben ebből nem vonódnak le költségek.
Teleflex Incorporated bevételtörténete 2000 és 2026 között
Bevétel az év végén
| Év | Bevétel | Változtassa meg |
|---|---|---|
| 2026 (TTM) | $2.60B | -14.66% |
| 2024 | $3.05B | 2.45% |
| 2023 | $2.97B | 6.57% |
| 2022 | $2.79B | -0.66% |
| 2021 | $2.81B | 10.74% |
| 2020 | $2.54B | -2.24% |
| 2019 | $2.60B | 6.00% |
| 2018 | $2.45B | 14.07% |
| 2017 | $2.15B | 14.90% |
| 2016 | $1.87B | 3.22% |
| 2015 | $1.81B | -1.64% |
| 2014 | $1.84B | 8.46% |
| 2013 | $1.70B | 9.37% |
| 2012 | $1.55B | 1.45% |
| 2011 | $1.53B | -15.14% |
| 2010 | $1.80B | -4.67% |
| 2009 | $1.89B | -21.93% |
| 2008 | $2.42B | 25.16% |
| 2007 | $1.93B | -26.92% |
| 2006 | $2.65B | 5.26% |
| 2005 | $2.51B | 1.17% |
| 2004 | $2.49B | 8.89% |
| 2003 | $2.28B | 9.93% |
| 2002 | $2.08B | 8.99% |
| 2001 | $1.91B | 7.96% |
| 2000 | $1.76B | 0.00% |
Hasonló cégek vagy versenytársak bevétele
| Vállalat | Bevétel | Bevételkülönbség | Ország |
|---|---|---|---|
| $11.03B | 324.30% |
US
|
|
| $34.74B | 1,235.71% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 701.32% |
US
|
|
| - | - |
CH
|
